Behavioral side effects of pediatric acute lymphoblastic leukemia treatment: The role of parenting strategies

2014 ◽  
Vol 61 (11) ◽  
pp. 2065-2070 ◽  
Author(s):  
Lauren K. Williams ◽  
Karen E. Lamb ◽  
Maria C. McCarthy
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
Side Effects ◽  
Lymphoblastic Leukemia ◽  
Parenting Strategies ◽  
Pediatric Acute Lymphoblastic Leukemia ◽  
Leukemia Treatment

scholarly journals A review of pharmacogenetic aspects of methotrexate and 6-mercaptopurine toxicity in pediatric acute lymphoblastic leukemia treatment

2021 ◽  
Vol 8 (3) ◽  
pp. 79-85
Author(s):  
О. D. Gurieva ◽  
М. I. Savelyeva ◽  
Т. Т. Valiev
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
Side Effects ◽  
Supportive Care ◽  
Lymphoblastic Leukemia ◽  
Molecular Profiling ◽  
Significant Progress ◽  
Pediatric Acute Lymphoblastic Leukemia ◽  
Leukemia Treatment ◽  
Risk Of Relapse

Significant progress in the treatment of acute lymphoblastic leukemia (ALL) in children has resulted from the development of effective chemoand supportive care therapy protocols. The vector of further research is aimed at reducing toxicity and long-term side effects. The study of pharmacogenetic aspects of toxicity of the main drugs used in the treatment of ALL – methotrexate and 6-mercaptopurine – allowed to identify oligonucleotide polymorphisms that correlate with the concentration of the drug in blood, toxic effects and the risk of relapse of ALL. The clinical administration of pharmacogenetic methods remains a challenging task, requiring additional research, which will make it possible to individualize the ALL therapy on the basis of the results of molecular profiling.

Current and future role of bispecific T-cell engagers in pediatric acute lymphoblastic leukemia

2018 ◽  
Vol 11 (12) ◽  
pp. 945-956 ◽  
Author(s):  
Mattia Algeri ◽  
Francesca Del Bufalo ◽  
Federica Galaverna ◽  
Franco Locatelli
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
T Cell ◽  
Lymphoblastic Leukemia ◽  
Pediatric Acute Lymphoblastic Leukemia ◽  
Future Role

scholarly journals Role of BIRC5 Gene as a Prognostic Marker in Pediatric Acute Lymphoblastic Leukemia

2017 ◽  
Vol 07 (01) ◽  
Author(s):  
Al Sharkawy E ◽  
Ghobrial AG ◽  
Eldin AMK ◽  
Saber MM ◽  
Aboul Fotoh LE ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
Prognostic Marker ◽  
Lymphoblastic Leukemia ◽  
Pediatric Acute Lymphoblastic Leukemia

The role of CDKN2A/B deletions in pediatric acute lymphoblastic leukemia

2016 ◽  
Vol 33 (7-8) ◽  
pp. 415-422 ◽  
Author(s):  
P. Carrasco Salas ◽  
L. Fernández ◽  
M. Vela ◽  
D. Bueno ◽  
B. González ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
Lymphoblastic Leukemia ◽  
Pediatric Acute Lymphoblastic Leukemia

Predicting the neurobehavioral side effects of dexamethasone in pediatric acute lymphoblastic leukemia

2016 ◽  
Vol 72 ◽  
pp. 190-195 ◽  
Author(s):  
Lidewij T. Warris ◽  
Erica L.T. van den Akker ◽  
Femke K. Aarsen ◽  
Marc B. Bierings ◽  
Cor van den Bos ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
Side Effects ◽  
Lymphoblastic Leukemia ◽  
Pediatric Acute Lymphoblastic Leukemia
Sign in / Sign up

Export Citation Format

Share Document